Can a simple card keep cancer patients safer?

NCT ID NCT04931329

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving cancer patients a drug vigilance card helps them avoid medication errors and interactions when seeing other doctors. One hundred patients on oral chemotherapy or targeted therapies at Limoges University Hospital will use the card. Researchers will measure patient and caregiver satisfaction and medication compliance at three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that a simple card helps cancer patients avoid dangerous drug interactions and take their medications correctly.

What could go wrong

This is a small, single-center study measuring satisfaction and compliance, not clinical outcomes. It may not prove the card improves safety or be generalizable to other hospitals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematologic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Limoges

    Limoges, 87042, France